SQUAMOUS CELL CARCINOMA ANTIGEN RECOGNIZED BY T-CELLS 3 302-310 LEUKOCYTE ANTIGEN A2 RESTRICTED
UNII SPJ354R9HT

Substance Identification & Data

This profile provides standardized clinical and technical data for Squamous Cell Carcinoma Antigen Recognized By T-cells 3 302-310 Leukocyte Antigen A2 Restricted, uniquely identified by the FDA Unique Ingredient Identifier (UNII) SPJ354R9HT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 260388-30-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
SPJ354R9HT
CAS Registry Number
260388-30-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SQUAMOUS CELL CARCINOMA ANTIGEN RECOGNIZED BY T-CELLS 3 302-310 LEUKOCYTE ANTIGEN A2 RESTRICTED
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Squamous Cell Carcinoma Antigen Recognized By T-cells 3 302-310 Leukocyte Antigen A2 Restricted. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

L-LEUCINE, L-LEUCYL-L-LEUCYL-L-GLUTAMINYL-L-ALANYL-L-.ALPHA.-GLUTAMYL-L-ALANYL-L-PROLYL-L-ARGINYL-
L-LEUCYL-L-LEUCYL-L-GLUTAMINYL-L-ALANYL-L-.ALPHA.-GLUTAMYL-L-ALANYL-L-PROLYL-L-ARGINYL-L-LEUCINE
SART3 302-310
SQUAMOUS CELL CARCINOMA ANTIGEN RECOGNIZED BY T-CELLS 3 302-310 LEUKOCYTE ANTIGEN A2 RESTRICTED

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record